Literature DB >> 12163573

Involvement of the leader sequence in Sendai virus pathogenesis revealed by recovery of a pathogenic field isolate from cDNA.

Yutaka Fujii1, Takemasa Sakaguchi, Katsuhiro Kiyotani, Cheng Huang, Noriko Fukuhara, Yoshiko Egi, Tetsuya Yoshida.   

Abstract

We previously demonstrated that a systematic passage of a pathogenic field isolate of Sendai virus (SeV), the Hamamatsu strain, in embryonated eggs caused attenuation of virulence to mice, and we isolated viral clones of distinct virulence (K. Kiyotani et al. Arch. Virol. 146:893-908, 2001). One of the clones, E15cl2, which was obtained from the virus at the 15th egg passage of E0, the parental Hamamatsu clone for egg passage, had 165-fold-attenuated virulence to mice and possessed only four mutations in the entire 15,384-base genome: in an antigenomic sense, U to A at position 20 (U20A) and U to A at position 24 (U24A) in the leader sequence, the promoter for transcription and replication, and A to G at position 9346 (silent) and A to U at position 12174 (Ser to Cys) in the L gene. To examine the possibility that leader mutations affect virus pathogenesis, we recovered live viruses from cDNA derived from the Hamamatsu strain. A mutant virus possessing either a mutation of U20A or U24A in the leader sequence showed a slightly lower pathogenicity than that of the parental virus, whereas a double mutant virus possessing both of the mutations showed 25-fold-attenuated virulence, accompanying a significantly lower virus replication in the mouse lung. Replications of the leader mutant viruses were also impaired in a primary culture of mouse pulmonary epithelial cells but not in chicken embryo fibroblasts. These findings suggest that leader mutations of SeV affect virus pathogenesis by altering virus replication in a host-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163573      PMCID: PMC136997          DOI: 10.1128/jvi.76.17.8540-8547.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Site-directed mutagenesis of virtually any plasmid by eliminating a unique site.

Authors:  W P Deng; J A Nickoloff
Journal:  Anal Biochem       Date:  1992-01       Impact factor: 3.365

2.  A protease activation mutant, MVCES1, as a safe and potent live vaccine derived from currently prevailing Sendai virus.

Authors:  X L Wang; M Itoh; H Hotta; M Homma
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

3.  Newcastle disease virus evolution. I. Multiple lineages defined by sequence variability of the hemagglutinin-neuraminidase gene.

Authors:  T Sakaguchi; T Toyoda; B Gotoh; N M Inocencio; K Kuma; T Miyata; Y Nagai
Journal:  Virology       Date:  1989-04       Impact factor: 3.616

4.  A field isolate of Sendai virus: its high virulence to mice and genetic divergence form prototype strains.

Authors:  T Sakaguchi; K Kiyotani; M Sakaki; Y Fujii; T Yoshida
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

5.  Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs.

Authors:  M Tashiro; M Homma
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

6.  Identification of endoprotease activity in the trans Golgi membranes of rat liver cells that specifically processes in vitro the fusion glycoprotein precursor of virulent Newcastle disease virus.

Authors:  T Sakaguchi; Y Matsuda; R Kiyokage; N Kawahara; K Kiyotani; N Katunuma; Y Nagai; T Yoshida
Journal:  Virology       Date:  1991-10       Impact factor: 3.616

7.  Correlation of proteolytic cleavage of F protein precursors in paramyxoviruses with expression of the fur, PACE4 and PC6 genes in mammalian cells.

Authors:  T Sakaguchi; Y Fujii; K Kiyotani; T Yoshida
Journal:  J Gen Virol       Date:  1994-10       Impact factor: 3.891

8.  Rescue of synthetic genomic RNA analogs of rabies virus by plasmid-encoded proteins.

Authors:  K K Conzelmann; M Schnell
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  Specific interaction in vitro and in vivo of glyceraldehyde-3-phosphate dehydrogenase and LA protein with cis-acting RNAs of human parainfluenza virus type 3.

Authors:  B P De; S Gupta; H Zhao; J A Drazba; A K Banerjee
Journal:  J Biol Chem       Date:  1996-10-04       Impact factor: 5.157

10.  A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus.

Authors:  D Garcin; T Pelet; P Calain; L Roux; J Curran; D Kolakofsky
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  5 in total

1.  A Single Amino Acid Substitution within the Paramyxovirus Sendai Virus Nucleoprotein Is a Critical Determinant for Production of Interferon-Beta-Inducing Copyback-Type Defective Interfering Genomes.

Authors:  Asuka Yoshida; Ryoko Kawabata; Tomoyuki Honda; Kouji Sakai; Yasushi Ami; Takemasa Sakaguchi; Takashi Irie
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

2.  The properties of recombinant Sendai virus having the P gene of Sendai virus pi strain derived from BHK cells persistently infected with Sendai virus.

Authors:  Machiko Nishio; Ai Nagata; Ayako Yamamoto; Masato Tsurudome; Morihiro Ito; Mitsuo Kawano; Hiroshi Komada; Yasuhiko Ito
Journal:  Med Microbiol Immunol       Date:  2006-02-08       Impact factor: 3.402

3.  Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy.

Authors:  Crystal W Burke; John N Mason; Sherri L Surman; Bart G Jones; Emilie Dalloneau; Julia L Hurwitz; Charles J Russell
Journal:  PLoS Pathog       Date:  2011-07-07       Impact factor: 6.823

4.  Sendai virus intra-host population dynamics and host immunocompetence influence viral virulence during in vivo passage.

Authors:  José Peña; Haiyin Chen-Harris; Jonathan E Allen; Mona Hwang; Maher Elsheikh; Shalini Mabery; Helle Bielefeldt-Ohmann; Adam T Zemla; Richard A Bowen; Monica K Borucki
Journal:  Virus Evol       Date:  2016-04-09

5.  IFN-β-inducing, unusual viral RNA species produced by paramyxovirus infection accumulated into distinct cytoplasmic structures in an RNA-type-dependent manner.

Authors:  Asuka Yoshida; Ryoko Kawabata; Tomoyuki Honda; Keizo Tomonaga; Takemasa Sakaguchi; Takashi Irie
Journal:  Front Microbiol       Date:  2015-08-04       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.